Oliver Uecke’s Post

Join me at Frontiers Health 2024 as I unveil Germany’s Tech Transfer Revolution in a fireside chat with Nicole Hecht! Curious about latest trends in tech transfer and why Saxony is a biotech powerhouse? Here is a sneak peek of what I will be talking about at the event. 👉 A general "one-size-fits-all" mentality regarding tech transfer doesn’t work for the highly regulated, high-risk, and capital-intensive life sciences sector which requires a life science-specific, comprehensive tech transfer ecosystem with interconnected support platforms. 👉 Focusing on later stage innovators like the biosaxony accelerator Medical Forge bridging the final steps to bring medical products from development to the clinic and thus to patients 👉 Saxony’s achievements include a €200 million investment 25 years ago leading to 300 companies and research institutions, employing over 15.500 people and generating nearly two billion euros in annual revenue today and our first Nobel Prize winner in Medicine. Saxony is leading in cell and gene therapy, cell biology, and radiopharmacy. 👉 Saxony is attractive for research and companies with cutting-edge research institutes like Max-Planck and dynamic SMEs. biosaxony is driving growth and supporting startups and SMEs through initiatives like Medical Forge and new life science VC funds. Saxony is the place to be for biotech innovation. Considering future biotech business or research opportunities? Come join the event and learn how to revolutionize tech transfer and look no further than Saxony – a hub of innovation and excellence! October 17-18, 2024, at Frontiers Health in Berlin. https://lnkd.in/eVSQ53gc #Biotech #Innovation #Saxony #BusinessOpportunity #ResearchOpportunity #FutureOfMedicine #Biosaxony #MedicalForge #techtransfer #commercilization #FH24 #MEDICALFORGE Lipotype biosaxony #nukliD Saxony Trade & Invest Corp. Dresden Tomorrow's Home (Wirtschaftsförderung Dresden) Dezernat für Wirtschaft, Arbeit und Digitales Stadt Leipzig Nana Bit-Avragim (she/her) Hi I am Oliver - CEO of Lipotype Inc., COO Lipotype and Chairman of board biosaxony. We are revolutionizing R&D with lipidomics. Like my post? Follow for more 🚀